These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 18574781

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS, Prieve BA.
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [Abstract] [Full Text] [Related]

  • 3. Human frequency-following response correlates of the distortion product at 2F1-F2.
    Pandya PK, Krishnan A.
    J Am Acad Audiol; 2004 Mar; 15(3):184-97. PubMed ID: 15119460
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sensitive response to low-frequency cochlear distortion products in the auditory midbrain.
    Abel C, Kössl M.
    J Neurophysiol; 2009 Mar; 101(3):1560-74. PubMed ID: 19036870
    [Abstract] [Full Text] [Related]

  • 6. Determining the cause of hearing loss: differential diagnosis using a comparison of audiometric and otoacoustic emission responses.
    Mills DM.
    Ear Hear; 2006 Oct; 27(5):508-25. PubMed ID: 16957501
    [Abstract] [Full Text] [Related]

  • 7. Fine alterations of distortion-product otoacoustic emissions after moderate acoustic overexposure in guinea pigs.
    Kossowski M, Mom T, Guitton M, Poncet JL, Bonfils P, Avan P.
    Audiology; 2001 Oct; 40(3):113-22. PubMed ID: 11465293
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM, Feeney MP, Gates GA.
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of aspirin on phase gradient of 2F1-F2 distortion product otoacoustic emissions.
    Parazzini M, Hall AJ, Lutman ME, Kapadia S.
    Hear Res; 2005 Jul; 205(1-2):44-52. PubMed ID: 15953514
    [Abstract] [Full Text] [Related]

  • 14. Parameters to maximize 2f2-f1 distortion product otoacoustic emission levels.
    Horn JH, Pratt SR, Durrant JD.
    J Speech Lang Hear Res; 2008 Dec; 51(6):1620-9. PubMed ID: 18664689
    [Abstract] [Full Text] [Related]

  • 15. Middle ear and cochlear disorders result in different DPOAE growth behaviour: implications for the differentiation of sound conductive and cochlear hearing loss.
    Gehr DD, Janssen T, Michaelis CE, Deingruber K, Lamm K.
    Hear Res; 2004 Jul; 193(1-2):9-19. PubMed ID: 15219315
    [Abstract] [Full Text] [Related]

  • 16. Extraction of sources of distortion product otoacoustic emissions by onset-decomposition.
    Vetesník A, Turcanu D, Dalhoff E, Gummer AW.
    Hear Res; 2009 Oct; 256(1-2):21-38. PubMed ID: 19523509
    [Abstract] [Full Text] [Related]

  • 17. Changes in input/output function of distortion product otoacoustic emissions during the glycerol test in Ménière's disease.
    Sakashita T, Shibata T, Yamane H, Hikawa C.
    Acta Otolaryngol Suppl; 2004 Oct; (554):26-9. PubMed ID: 15513506
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.